Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Journal for Immunotherapy of Cancer
|
March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.
Nature Medicine
|
August 17, 2023
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
Ari VanderWalde, Shay L Bellasea, Kari L Kendra, et al.
Nature Medicine
|
August 26, 2025
Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial
Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Nature Cancer
|
January 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial
Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Transplantation and Cellular Therapy
|
December 20, 2025
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients
Lilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, et al.
The Lancet. Oncology
|
May 17, 2021
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, et al.
Lancet (London, England)
|
September 15, 2022
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
Sungjune Kim, Evan Wuthrick, Dukagjin Blakaj, et al.
Nature Medicine
|
August 14, 2025
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial
Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
Eclinicalmedicine
|
October 23, 2025
Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study
Jessica S W Borgers, Douglas B Johnson, Elisabeth Livingstone, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Journal for Immunotherapy of Cancer
|
March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.
Nature Medicine
|
August 17, 2023
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
Ari VanderWalde, Shay L Bellasea, Kari L Kendra, et al.
Nature Medicine
|
August 26, 2025
Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial
Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Nature Cancer
|
January 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial
Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
Transplantation and Cellular Therapy
|
December 20, 2025
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients
Lilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, et al.
The Lancet. Oncology
|
May 17, 2021
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, et al.
Lancet (London, England)
|
September 15, 2022
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
Sungjune Kim, Evan Wuthrick, Dukagjin Blakaj, et al.
Nature Medicine
|
August 14, 2025
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial
Kari L Kendra, Shay L Bellasea, Zeynep Eroglu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
Eclinicalmedicine
|
October 23, 2025
Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study
Jessica S W Borgers, Douglas B Johnson, Elisabeth Livingstone, et al.
Page
of 12